CONMED Corporation to Present at the J.P. Morgan Healthcare Conference

UTICA, N.Y.–(BUSINESS WIRE)–CONMED Corporation (NASDAQ: CNMD) today announced that Curt R. Hartman, President and Chief Executive Officer, and Todd W. Garner, Executive Vice President and Chief Financial Officer, will present at the 38th Annual J.P. Morgan Healthcare Conference at 4:30 p.m. PT on Monday, January 13, 2020 in San Francisco, CA.

A live webcast of the presentation and Q&A breakout session will be accessible through the “Investors” section of the Company’s website at www.conmed.com and will be available for replay following the event.

About CONMED Corporation

CONMED is a medical technology company that provides surgical devices and equipment for minimally invasive procedures. The Company’s products are used by surgeons and physicians in a variety of specialties, including orthopedics, general surgery, gynecology, neurosurgery, thoracic surgery, and gastroenterology. For more information, visit www.conmed.com.

Forward-Looking Statements

This press release may contain forward-looking statements based on certain assumptions and contingencies that involve risks and uncertainties, which could cause actual results, performance, or trends to differ materially from those expressed in the forward-looking statements herein or in previous disclosures. For example, in addition to general industry and economic conditions, factors that could cause actual results to differ materially from those in the forward-looking statements may include, but are not limited to, the risk factors discussed in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2018 and listed under the heading Forward-Looking Statements in the Company’s most recently filed Form 10-Q. Any and all forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and relate to the Company’s performance on a going-forward basis. The Company believes that all forward-looking statements made by it have a reasonable basis, but there can be no assurance that management’s expectations, beliefs or projections as expressed in the forward-looking statements will actually occur or prove to be correct.

Contacts

CONMED Corporation
Todd W. Garner
Chief Financial Officer
315-624-3317
ToddGarner@conmed.com

Staff

Recent Posts

Grace Health Technology Launches New Laboratory Management Software

Live Sample Management Application Streamlines Laboratory Operations Software for Enhanced Laboratory Data Management Efficiency Secures…

2 hours ago

Avenues Recovery Center to Open at South Bend

Avenues Recovery is set to open a brand-new, 120-bed facility in Mishawaka, IndianaMISHAWAKA, IN /…

2 hours ago

Bristol Myers Squibb Expands Health Equity Grant Initiatives to Improve Health Outcomes

Company Awards $1.8M in Grants to Eight Organizations in Brazil, India, Thailand and the United…

5 hours ago

Universal Recall Platform Alliance Launches to Keep Patients Safe

Industry initiative URPA broadens calls to improve speed, accuracy of recall communicationWEST HOLLYWOOD, CA /…

5 hours ago

Elicio Therapeutics Reports 2023 Financial Results and Provides Corporate Updates

ELI-002 2P clinical immunogenicity data were accepted for a poster presentation at the AACR Annual…

8 hours ago

Molecular Templates, Inc. Reports Fourth Quarter 2023 Financial Results and Business Update

AUSTIN, Texas, March 29, 2024 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or…

8 hours ago